Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02040545 · ClinicalTrials.gov registry record

Salivary Diagnostic Testing for IVF

A clinical trial of Infertility, sponsored by Boston IVF.

Completed
Registry status
335
Enrollment target
8
Study locations

NCT02040545 is a study of Infertility that has completed, run by Boston IVF. The registered enrollment target is 335 participants, below the 7,585-participant average among 74 other Infertility trials with a reported enrollment target (96% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02040545, a study of Infertility, has completed, sponsored by Boston IVF.

COMPLETED
Registry status
335 participants
Enrollment target
8
Study locations

Study Summary

This study aims to determine the performance of a salivary hormone competitive immunoassay for monitoring patients during treatment for infertility.

Conditions Studied

Study Locations (8)

Massachusetts

  • Boston IVF - Quincy
  • Boston IVF - Waltham

California

  • HRC Fertility - Pasadena

Georgia

  • Reproductive Biology Associates - Atlanta

Illinois

  • Fertility Center of Illinois - Chicago

Maine

  • Boston IVF - South Portland

Maryland

  • Shady Grove Fertility Reproductive Science Center - Rockville

New York

  • Reproductive Medicine Associates of New York, LLP - New York

Trial Details

FieldValue
Enrollment Target 335 participants
Start Date 2010-05-21
Est. Completion 2017-04-04

Sponsor

Boston IVF

10 total trials

What the Registry Record Tells You About NCT02040545

The ClinicalTrials.gov registry entry for NCT02040545 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 335 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,585-participant average among 74 other Infertility trials with a reported enrollment target (96% lower). The listed sponsor is Boston IVF, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 0 interventions.

NCT02040545 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Massachusetts, California, Georgia.

Frequently Asked Questions

What is clinical trial NCT02040545 about?

NCT02040545 is a clinical study titled "Salivary Diagnostic Testing for IVF". This study aims to determine the performance of a salivary hormone competitive immunoassay for monitoring patients during treatment for infertility.

What is the current status of trial NCT02040545?

This trial is currently completed. The enrollment target is 335 participants. The study started on 2010-05-21. Estimated completion is 2017-04-04.

What conditions does trial NCT02040545 study?

This clinical trial studies the following conditions: Infertility.

Who is sponsoring clinical trial NCT02040545?

This trial is sponsored by Boston IVF, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02040545 being conducted?

This trial has 8 study locations across California, Georgia, Illinois, Maine, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.